]
Holt RJ, Sklar AR, Darkow T, Goldberg GA, Johnson JC, Harley CR. Prevalence of Parkinson's disease-induced psychosis in a large u.s. Managed care population. J Neuropsychiatry Clin Neurosci. 2010;22(1):105-10.
Iwanami M, Miyamoto T, Miyamoto M, Hirata K, Takada E. Relevance of substantia nigra hyperechogenicity and reduced odor identification in idiopathic REM sleep behavior disorder. Sleep medicine. 2010.
Sohtaoğlu M, Demiray D, Kenangil G, Ozekmekçi S, Erginöz E. Long term follow-up of Parkinson' disease patients with impulse control disorders. Parkinsonism & related disorders. 2010.
Miller VM, Lawrence DA, Coccaro GA, Mondal TK, Andrews K, Dreiem A, et al. Sex effects of Interleukin-6 deficiency on neuroinflammation in aged C57Bl/6 mice. Brain Res. 2010;1318:11-22.
Unger MM, Hattemer K, Möller JC, Schmittinger K, Mankel K, Eggert K, et al. Real-time visualization of altered gastric motility by magnetic resonance imaging in patients with Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society. 2010.
Wypijewska A, Galazka-Friedman J, Bauminger ER, Wszolek ZK, Schweitzer KJ, Dickson DW, et al. Iron and reactive oxygen species activity in parkinsonian substantia nigra. Parkinsonism & related disorders. 2010.
Zhao Y, Wee H, Chan YH, Seah S, Au W, Lau P, et al. Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times. Movement disorders : official journal of the Movement Disorder Society. 2010.
Dalaker TO, Zivadinov R, Larsen JP, Beyer MK, Cox JL, Alves G, et al. Gray matter correlations of cognition in incident Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society. 2010.
Chung KA, Lobb BM, Nutt JG, McNames J, Horak F. Objective measurement of dyskinesia in Parkinson's disease using a force plate. Movement disorders : official journal of the Movement Disorder Society. 2010.
Moro E, Lozano AM, Pollak P, Agid Y, Rehncrona S, Volkmann J, et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society. 2010.
Mo JS, Jung J, Yoon JH, Hong JA, Kim MY, Ann EJ, et al. DJ-1 modulates the p38 mitogen-activated protein kinase pathway through physical interaction with apoptosis signal-regulating kinase 1. Journal of cellular biochemistry. 2010.
Adamiak U, Kaldonska M, Klodowska-Duda G, Wyska E, Safranow K, Bialecka M, et al. Pharmacokinetic-Pharmacodynamic Modeling of Levodopa in Patients With Advanced Parkinson Disease. Clinical neuropharmacology. 2010.
Hamza TH, Payami H. The heritability of risk and age at onset of Parkinson's disease after accounting for known genetic risk factors. Journal of human genetics. 2010.
Bayersdorfer F, Voigt A, Schneuwly S, Botella JA. Dopamine-dependent neurodegeneration in Drosophila models of familial and sporadic Parkinson's disease. Neurobiology of disease. 2010.
Lovitt B, Vanderporten EC, Sheng Z, Zhu H, Drummond J, Liu Y. Differential Effects of Divalent Manganese and Magnesium on the Kinase Activity of Leucine-Rich Repeat Kinase-2 (LRRK2). Biochemistry. 2010.
Luo N, Ng WY, Lau PN, Au WL, Tan LC. Responsiveness of the EQ-5D and 8-item Parkinson's Disease Questionnaire (PDQ-8) in a 4-year follow-up study. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2010.
Schneider JS, Sendek S, Daskalakis C, Cambi F. GM1 ganglioside in Parkinson's disease: Results of a five year open study. Journal of the neurological sciences. 2010.
Paleologou KE, Oueslati A, Shakked G, Rospigliosi CC, Kim HY, Lamberto GR, et al. Phosphorylation at S87 Is Enhanced in Synucleinopathies, Inhibits {alpha}-Synuclein Oligomerization, and Influences Synuclein-Membrane Interactions. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2010;30(9):3184-98.
Mak SK, McCormack AL, Manning-Bog AB, Cuervo A, Di Monte DA. Lysosomal degradation of {alpha}-synuclein in vivo. The Journal of biological chemistry. 2010.
Bordia T, Campos C, McIntosh MJ, Quik M. Nicotinic receptor-mediated reduction in L-dopa-induced dyskinesias may occur via desensitization. The Journal of pharmacology and experimental therapeutics. 2010.
Drescher M, van Rooijen BD, Veldhuis G, Subramaniam V, Huber M. A Stable Lipid-Induced Aggregate of alpha-Synuclein. Journal of the American Chemical Society. 2010.
Wider C, Dickson DW, Wszolek ZK. Leucine-Rich Repeat Kinase 2 Gene-Associated Disease: Redefining Genotype-Phenotype Correlation. Neuro-degenerative diseases. 2010;7(1-3):175-9.
Monaghan MM, Leddy L, Sung ML, Albinson K, Kubek K, Pangalos MN, et al. Social Odor Recognition: A Novel Behavioral Model for Cognitive Dysfunction in Parkinson's Disease. Neuro-degenerative diseases. 2010;7(1-3):153-9.
Tsika E, Moysidou M, Guo J, Cushman M, Gannon P, Sandaltzopoulos R, et al. Distinct Region-Specific {alpha}-Synuclein Oligomers in A53T Transgenic Mice: Implications for Neurodegeneration. J Neurosci. 2010;30(9):3409-18.